These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24248320)

  • 21. [Acrocyanosis, Raynaud's phenomenon and digital gangrene in a case of systemic lupus erythematosus].
    Montuori R; Riccardi C
    Minerva Med; 1968 Feb; 59(10):515-21. PubMed ID: 5642234
    [No Abstract]   [Full Text] [Related]  

  • 22. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
    Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
    J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thermographic assessment of Raynaud's phenomenon in childhood mixed connective tissue disease].
    Yokota S; Kuriyama T; Takahashi Y; Mori M; Shike H; Ibe M; Mitsuda T; Aihara Y
    Ryumachi; 1994 Dec; 34(6):955-60. PubMed ID: 7863385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iloprost infusion through elastomeric pump for the outpatient treatment of severe Raynaud's phenomenon and digital ulcers - a single centre experience.
    Duarte AC; Barbosa L; Santos MJ; Cordeiro A
    Acta Reumatol Port; 2018; 43(3):237-238. PubMed ID: 30414374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypereosinophilic syndrome presenting as cutaneous necrotizing eosinophilic vasculitis and Raynaud's phenomenon complicated by digital gangrene.
    Jang KA; Lim YS; Choi JH; Sung KJ; Moon KC; Koh JK
    Br J Dermatol; 2000 Sep; 143(3):641-4. PubMed ID: 10971345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-Traumatic Raynaud's Phenomenon: A Case Report.
    Cheok LJ; Ooi CK
    J Emerg Med; 2017 Jun; 52(6):e237-e238. PubMed ID: 28256352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Raynaud's phenomenon - first sign of malignancy: case report].
    Sutić A; Gračanin G; Morović-Vergles J
    Acta Med Croatica; 2014 Jun; 68(3):295-8. PubMed ID: 26016221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus.
    Ingegnoli F; Schioppo T; Allanore Y; Caporali R; Colaci M; Distler O; Furst DE; Hunzelmann N; Iannone F; Khanna D; Matucci-Cerinic M
    Semin Arthritis Rheum; 2019 Feb; 48(4):686-693. PubMed ID: 29706243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is iloprost effective in secondary Raynaud's phenomenon?
    Lustig N; Rada G
    Medwave; 2015 Mar; 15(2):e6082. PubMed ID: 25826330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study.
    Kawald A; Burmester GR; Huscher D; Sunderkötter C; Riemekasten G
    J Rheumatol; 2008 Sep; 35(9):1830-7. PubMed ID: 18634152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial fingertip necrosis following a digital surgical procedure in a patient with primary Raynaud's phenomenon.
    Uygur S; Tuncer S
    Int Wound J; 2014 Dec; 11(6):581-2. PubMed ID: 25200107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled iloprost for the treatment of Raynaud's phenomenon.
    Pakozdi A; Howell K; Wilson H; Fox S; Gonzalez L; Black CM; Denton CP
    Clin Exp Rheumatol; 2008; 26(4):709. PubMed ID: 18799113
    [No Abstract]   [Full Text] [Related]  

  • 33. Continuous regional anesthesia before surgical peripheral sympathectomy in a patient with severe digital necrosis associated with Raynaud's phenomenon and scleroderma.
    Greengrass RA; Feinglass NG; Murray PM; Trigg SD
    Reg Anesth Pain Med; 2003; 28(4):354-8. PubMed ID: 12945033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Raynaud's phenomenon.
    Devgire V; Hughes M
    Br J Hosp Med (Lond); 2019 Nov; 80(11):658-664. PubMed ID: 31707892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
    Gerbracht DD; Steen VD; Ziegler GL; Medsger TA; Rodnan GP
    Arthritis Rheum; 1985 Jan; 28(1):87-92. PubMed ID: 3871330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raynaud's phenomenon.
    O'connor CM
    J Vasc Nurs; 2001 Sep; 19(3):87-92; quiz 93-4. PubMed ID: 11533581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Raynaud's phenomenon and digital necrosis induced by interferon-alpha.
    Bachmeyer C; Farge D; Gluckman E; Miclea JM; Aractingi S
    Br J Dermatol; 1996 Sep; 135(3):481-3. PubMed ID: 8949451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cocaine-Induced raynaud's phenomenon and ischaemic finger necrosis.
    Balbir-Gurman A; Braun-Moscovici Y; Nahir AM
    Clin Rheumatol; 2001; 20(5):376-8. PubMed ID: 11642523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of long-term iloprost therapy on Raynaud's phenomenon in progressive systemic sclerosis].
    Cordioli E; Virgilio S; Ghirardi R; Martinelli M
    Minerva Med; 1992 Nov; 83(11):739-44. PubMed ID: 1281297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypereosinophilia-induced digital necrosis in a smoking patient.
    Stephan D; Lipsker D; Sens P; Hassani S; Welsch M
    Int Angiol; 2003 Mar; 22(1):95-7. PubMed ID: 12771865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.